Charles Schwab Investment Management Inc Nkarta, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $527 Billion
  • Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Nkarta, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 125,013 shares of NKTX stock, worth $265,027. This represents 0.0% of its overall portfolio holdings.

Number of Shares
125,013
Previous 145,332 13.98%
Holding current value
$265,027
Previous $656,000 52.59%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
SELL
$2.17 - $4.34 $44,092 - $88,184
-20,319 Reduced 13.98%
125,013 $311,000
Q2 2024

Aug 12, 2024
BUY
$5.27 - $10.82 $294,614 - $604,881
55,904 Added 62.51%
145,332 $858,000
Q1 2024

May 08, 2024
BUY
$5.59 - $15.71 $113,583 - $319,211
20,319 Added 29.4%
89,428 $966,000
Q3 2023

Nov 08, 2023
SELL
$1.39 - $2.29 $241,481 - $397,837
-173,728 Reduced 71.54%
69,109 $96,000
Q2 2023

Aug 09, 2023
BUY
$2.19 - $5.17 $5,490 - $12,961
2,507 Added 1.04%
242,837 $531,000
Q1 2023

May 11, 2023
SELL
$3.37 - $6.3 $41,700 - $77,956
-12,374 Reduced 4.9%
240,330 $853,000
Q4 2022

Feb 13, 2023
BUY
$5.14 - $14.35 $23,746 - $66,297
4,620 Added 1.86%
252,704 $1.51 Million
Q3 2022

Nov 14, 2022
BUY
$12.27 - $18.39 $471,487 - $706,654
38,426 Added 18.33%
248,084 $3.27 Million
Q2 2022

Aug 15, 2022
BUY
$7.77 - $19.44 $891,661 - $2.23 Million
114,757 Added 120.92%
209,658 $2.58 Million
Q1 2022

May 13, 2022
SELL
$8.66 - $14.99 $54,445 - $94,242
-6,287 Reduced 6.21%
94,901 $1.08 Million
Q4 2021

Feb 11, 2022
BUY
$12.79 - $26.88 $39,840 - $83,731
3,115 Added 3.18%
101,188 $1.55 Million
Q3 2021

Nov 16, 2021
SELL
$26.67 - $38.76 $254,485 - $369,847
-9,542 Reduced 8.87%
98,073 $2.73 Million
Q2 2021

Aug 16, 2021
SELL
$23.94 - $36.68 $274,879 - $421,159
-11,482 Reduced 9.64%
107,615 $3.41 Million
Q1 2021

May 17, 2021
BUY
$31.33 - $59.61 $360,451 - $685,813
11,505 Added 10.69%
119,097 $3.92 Million
Q4 2020

Feb 16, 2021
BUY
$27.03 - $75.62 $36,544 - $102,238
1,352 Added 1.27%
107,592 $6.61 Million
Q3 2020

Nov 13, 2020
BUY
$23.52 - $47.9 $2.5 Million - $5.09 Million
106,240 New
106,240 $3.19 Million

Others Institutions Holding NKTX

# of Institutions
122
Shares Held
69.3M
Call Options Held
173K
Put Options Held
20K
View Full List

About Nkarta, Inc.

NKTX Quotes by TradingView
  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $103M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email